相关实验视频
Updated: Jul 20, 2025

09:41
Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
12.2K
发现了增强免疫疗法的小分子β-catenin抑制剂
Xuchen Feng1, Jun Ge1, Hui Fu2
1College of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
Bioorganic chemistry
|August 3, 2023
概括
来自Dan-Shen-Su (DSS) 的新药有效降低β-catenin的调节,β-catenin是癌症干细胞治疗的关键标. 这些化合物在改善存活率和增强对瘤的免疫反应方面表现有前途.
科学领域:
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 针对β-catenin对于癌症干细胞治疗至关重要,但有效的抑制剂是有限的.
- 乙素对β-catenin的亲和力表明,增加其表达可以调节β-catenin水平.
- 对于Wnt/β-catenin通路失调的现有疗法具有显著的临床局限性.
研究的目的:
- 发现和描述用于直接降低β-catenin调节的新型小分子.
- 在临床前癌症模型中评估丹-申-苏 (DSS) 衍生化合物的治疗潜力.
- 研究这些新型化合物的抗癌作用背后的机制.
主要方法:
- 合成和选由丹-申-苏 (DSS) 衍生的以基药物.
- 对β-catenin下调和E-cadherin表达调节的评估.
- 在术后小鼠治疗疗效的评估,包括生存率.
- 结合疗法研究与PD-L1检查点阻塞.
- 机制研究,包括维生素D受体激动性评估.
主要成果:
- 发现了DSS-C12和DSS-B8,它们是强大的β-catenin下调调剂.
- 用DSS化合物治疗的小鼠的整体存活率有明显改善.
- 当与PD-L1阻断相结合时,增强了全身免疫反应和显著的原发性瘤生长抑制.
- DSS-B8被确定为维生素D受体激动剂,但不会导致高热血症.
结论:
- 由DSS衍生的小分子为直接β-catenin停活提供了一个有前途的治疗策略.
- 这些化合物在癌症治疗中具有临床应用的潜力,特别是在组合疗法中.
- 这些发现突出了针对癌症干细胞和增强抗瘤免疫力的新方法.
相关概念视频
Catenins
2.3K
Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
2.3K
Canonical Wnt Signaling Pathway
8.8K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
Tumor Immunotherapy
558
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
558
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K

